Product NewsClinical Diagnostics
Troponin I test demonstrates breakthrough performance
1 Apr 2024![Troponin I test demonstrates breakthrough performance Troponin I test demonstrates breakthrough performance](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/efa472752801511acc27d0a0a9d4d08a95be43c5-805x450.jpg?w=3840&q=75&fit=clip&auto=format)
The Quidel TriageTrue® High Sensitivity Troponin I Test was the only point-of-care (POC) included in the European Society of Cardiology guideline for the 0–1 hour algorithm protocol, with 74% of patients assigned to rule out or rule in zones within one hour, on par with top central lab assays. Dr. Ahmed Dakshi, a cardiology research fellow and principal investigator for the MACRO-2 trial, discusses the study and how he assessed the analytical and clinical performance of this latest POC offering from QuidelOrtho.